Cochrane Abstracts
Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Surfactant Therapy Via Thin Catheter in Preterm Infants With or at Risk of Respiratory Distress Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431521/all/Surfactant_therapy_via_thin_catheter_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome.
Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431521/all/Surfactant_therapy_via_thin_catheter_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome. Accessed January 22, 2025.
Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431521/all/Surfactant_therapy_via_thin_catheter_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome
Surfactant Therapy Via Thin Catheter in Preterm Infants With or at Risk of Respiratory Distress Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431521/all/Surfactant_therapy_via_thin_catheter_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome
ID - 431521
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431521/all/Surfactant_therapy_via_thin_catheter_in_preterm_infants_with_or_at_risk_of_respiratory_distress_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
